Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001387131-20-011272

10% owner bought 1,100,000 shares at $23.00 ($25,300,000)

  • 10% owner acquired 2,837,914 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
VIKING GLOBAL INVESTORS LP 10% owner 2020-12-15 Conversion +2,004,581 2,004,581 I
VIKING GLOBAL INVESTORS LP 10% owner 2020-12-15 Conversion +833,333 2,837,914 I
VIKING GLOBAL INVESTORS LP 10% owner 2020-12-15 Purchase +1,100,000 $23.00 $25,300,000 3,937,914 I
Derivatives
VIKING GLOBAL INVESTORS LP 10% owner 2020-12-15 Conversion · Series B Redeemable Convertible Preferred Stock −2,004,581 0 I
VIKING GLOBAL INVESTORS LP 10% owner 2020-12-15 Conversion · Series C Redeemable Convertible Preferred Stock −833,333 0 I
Open-market purchases · 1,100,000 sh · avg $23.00 · $25,300,000
Loading xslF345X03/fdmt-form4_121520.xml…